Ghent University Academic Bibliography

ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells

Hila Fishman, Shreyas Madiwale, Ifat Geron, Vase Bari, Wouter Van Loocke (UGent) , Yael Kirschenbaum, Itamar Ganmore, Eitan Kugler, Avigail Rein-Gil, Gilgi Friedlander, et al.

(2022) BLOOD. 139(3). p.399-412

Add to list

Journal Article
A1
open access

Functional mapping of PHF6 complexes in chromatin remodeling, replication dynamics and DNA repair

Silvia Alvarez, Ana da Silva Almeida, Robert Albero, Mayukh Biswas, Angelica Barreto-Galvez, Thomas S. Gunning, Anam Shaikh, Tomas Aparicio, Agnieszka Anya Wendorff, Erich Piovan, et al.

(2022) BLOOD. 139(23). p.3418-3429

Add to list

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies : results from EPICOVIDEHA survey

Livio Pagano, Jon Salmanton-García, Francesco Marchesi, Ola Blennow, Maria Gomes da Silva, Andreas Glenthøj, Jaap A. van Doesum, Yavuz M Bilgin, Alberto Lopez-Garcia, Federico Itri, et al.

(2022) BLOOD.

Add to list

Journal Article

Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia

Saara Laukkanen, Alexandra Veloso, Chuan Yan, Laura Oksa, Eric J. Alpert, Daniel Do, Noora Hyvärinen, Karin McCarthy, Abhinav Adhikari, Qiqi Yang, et al.

(2022) Blood. 140(17). p.1891-1906

Add to list

Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells

Paul Collins (UGent) , Christopher P. Fox, Lindsay George, Hayden Pearce, Gordon Ryan, Carmela De Santo, Frances Mussai, David Lewis, Heather Long and Claire Shannon-Lowe

(2021) BLOOD. 137(2). p.203-215

Add to list

Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

Thierry Facon, Christopher P. Venner, Nizar J. Bahlis, Fritz Offner (UGent) , Darrell J. White, Lionel Karlin, Lotfi Benboubker, Sophie Rigaudeau, Philippe Rodon, Eric Voog, et al.

(2021) BLOOD. 137(26). p.3616-3628

Add to list

Miscellaneous

CAR-T treatment of pediatric AML : a long and winding road

Barbara De Moerloose (UGent)

(2021) BLOOD. 137(8). p.1004-1006

Add to list

Association of unbalanced translocation der(1;7) with germline GATA2 mutations

Emilia J. Kozyra, Gudrun Goehring, Dennis D. Hickstein, Katherine R. Calvo, Courtney D. DiNardo, Michael Dworzak, Valerie de Haas, Jan Stary, Henrik Hasle, Akiko Shimamura, et al.

(2021) BLOOD. 138(23). p.2441-2445

Add to list

SOX11 functions as an oncogene in Lmo2-driven T-cell lymphoblastic leukemia (T-ALL)

André Pedro Pinto De Almeida (UGent) , Tim Pieters (UGent) , Sara T'Sas (UGent) , Steven Goossens (UGent) and Pieter Van Vlierberghe (UGent)

(2021) BLOOD. In Blood 138(Supplement 1). p.1136-1136

Add to list

Journal Article
A1
open access

The transcription factor ETS1 is an important regulator of human NK cell development and terminal differentiation

Sylvie Taveirne (UGent) , Sigrid Wahlen (UGent) , Wouter Van Loocke (UGent) , Laura Kiekens (UGent) , Eva Persyn (UGent) , Els Van Ammel (UGent) , Katrien De Mulder (UGent) , Juliette Roels (UGent) , Laurentijn Tilleman (UGent) , Marc Aumercier, et al.

(2020) BLOOD. 136(3). p.288-298

Academic Bibliography

ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells

Functional mapping of PHF6 complexes in chromatin remodeling, replication dynamics and DNA repair

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies : results from EPICOVIDEHA survey

Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia

Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells

Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

CAR-T treatment of pediatric AML : a long and winding road

Association of unbalanced translocation der(1;7) with germline GATA2 mutations

SOX11 functions as an oncogene in Lmo2-driven T-cell lymphoblastic leukemia (T-ALL)

The transcription factor ETS1 is an important regulator of human NK cell development and terminal differentiation

Contents

Support

Contact